Invizius completes first-in-human ‘angry blood’ dialysis study
13 Jun 2024 //
FIERCE BIOTECH
Invizius’s Pioneering Dialysis Product H-Guard® Completes First In-Human Study
22 May 2024 //
PHARMIWEB
Invizius Treats First Patients in Phase 1 Study of Lead Dialysis Product H-Guard
07 Feb 2024 //
PR NEWSWIRE
Invizius Receives MHRA Approval to Commence Study of H-Guard® Priming Solution
01 Aug 2023 //
PR NEWSWIRE
Invizius Awarded Major Biomedical Catalyst Grant
30 Mar 2022 //
PRNEWSWIRE
Invizius Announces Successful Series A Financing to Develop Anti-Inflammatory
06 May 2021 //
PRNEWSWIRE